Global Echinocandins for Injection Market Growth 2026-2032
The global Echinocandins for Injection market size is predicted to grow from US$ 973 million in 2025 to US$ 1277 million in 2032; it is expected to grow at a CAGR of 4.0% from 2026 to 2032.
Echinocandins are a class of antifungal drugs that inhibit the synthesis of ?-glucan in the fungal cell wall via noncompetitive inhibition of the enzyme 1,3-? glucan synthase. The class has been termed the "penicillin of antifungals," along with the related papulacandins, as their mechanism of action resembles that of penicillin in bacteria.
Echinocandins are a class of antifungal medications administered through injection, widely used to treat severe fungal infections. These drugs target the ?-1,3-glucan synthase enzyme in the fungal cell wall, leading to the inhibition of cell wall synthesis and subsequent fungal cell death. Common echinocandins include caspofungin, anidulafungin, and micafungin, often utilized in the treatment of refractory candidiasis such as invasive candidiasis. They typically require strict medical supervision and judicious use due to their lower toxicity targeting fungal cell wall synthesis, making them an important choice in combating fungal infections.
LP Information, Inc. (LPI) ' newest research report, the “Echinocandins for Injection Industry Forecast” looks at past sales and reviews total world Echinocandins for Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Echinocandins for Injection sales for 2026 through 2032. With Echinocandins for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Echinocandins for Injection industry.
This Insight Report provides a comprehensive analysis of the global Echinocandins for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Echinocandins for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Echinocandins for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Echinocandins for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Echinocandins for Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Echinocandins for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Echinocandins are a class of antifungal drugs that inhibit the synthesis of ?-glucan in the fungal cell wall via noncompetitive inhibition of the enzyme 1,3-? glucan synthase. The class has been termed the "penicillin of antifungals," along with the related papulacandins, as their mechanism of action resembles that of penicillin in bacteria.
Echinocandins are a class of antifungal medications administered through injection, widely used to treat severe fungal infections. These drugs target the ?-1,3-glucan synthase enzyme in the fungal cell wall, leading to the inhibition of cell wall synthesis and subsequent fungal cell death. Common echinocandins include caspofungin, anidulafungin, and micafungin, often utilized in the treatment of refractory candidiasis such as invasive candidiasis. They typically require strict medical supervision and judicious use due to their lower toxicity targeting fungal cell wall synthesis, making them an important choice in combating fungal infections.
LP Information, Inc. (LPI) ' newest research report, the “Echinocandins for Injection Industry Forecast” looks at past sales and reviews total world Echinocandins for Injection sales in 2025, providing a comprehensive analysis by region and market sector of projected Echinocandins for Injection sales for 2026 through 2032. With Echinocandins for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Echinocandins for Injection industry.
This Insight Report provides a comprehensive analysis of the global Echinocandins for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Echinocandins for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Echinocandins for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Echinocandins for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Echinocandins for Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of Echinocandins for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Caspofungin
- Micafungin
- Anidulafungin
- Hospital
- Drugstore
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Astellas
- Endo International
- Xellia Pharmaceuticals
- Teva
- Hikma
- Apotex
- Fresenius
- Pfizer
- CTTQ
- QILU Pharmaceutical
- BrightGene Bio-Medical Technology
- Hansoh Pharmaceutical
- HISUN
- What is the 10-year outlook for the global Echinocandins for Injection market?
- What factors are driving Echinocandins for Injection market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Echinocandins for Injection market opportunities vary by end market size?
- How does Echinocandins for Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Echinocandins for Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Echinocandins for Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Echinocandins for Injection by Country/Region, 2021, 2025 & 2032
2.2 Echinocandins for Injection Segment by Type
2.2.1 Caspofungin
2.2.2 Micafungin
2.2.3 Anidulafungin
2.2.4 Echinocandins for Injection Sales by Type
2.2.4.1 Global Echinocandins for Injection Sales Market Share by Type (2021-2026)
2.2.4.2 Global Echinocandins for Injection Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Echinocandins for Injection Sale Price by Type (2021-2026)
2.3 Echinocandins for Injection Segment by Application
2.3.1 Hospital
2.3.2 Drugstore
2.3.3 Echinocandins for Injection Sales by Application
2.3.3.1 Global Echinocandins for Injection Sale Market Share by Application (2021-2026)
2.3.3.2 Global Echinocandins for Injection Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Echinocandins for Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Echinocandins for Injection Breakdown Data by Company
3.1.1 Global Echinocandins for Injection Annual Sales by Company (2021-2026)
3.1.2 Global Echinocandins for Injection Sales Market Share by Company (2021-2026)
3.2 Global Echinocandins for Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Echinocandins for Injection Revenue by Company (2021-2026)
3.2.2 Global Echinocandins for Injection Revenue Market Share by Company (2021-2026)
3.3 Global Echinocandins for Injection Sale Price by Company
3.4 Key Manufacturers Echinocandins for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Echinocandins for Injection Product Location Distribution
3.4.2 Players Echinocandins for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ECHINOCANDINS FOR INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Echinocandins for Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Echinocandins for Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Echinocandins for Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Echinocandins for Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Echinocandins for Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Echinocandins for Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Echinocandins for Injection Sales Growth
4.4 APAC Echinocandins for Injection Sales Growth
4.5 Europe Echinocandins for Injection Sales Growth
4.6 Middle East & Africa Echinocandins for Injection Sales Growth
5 AMERICAS
5.1 Americas Echinocandins for Injection Sales by Country
5.1.1 Americas Echinocandins for Injection Sales by Country (2021-2026)
5.1.2 Americas Echinocandins for Injection Revenue by Country (2021-2026)
5.2 Americas Echinocandins for Injection Sales by Type (2021-2026)
5.3 Americas Echinocandins for Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Echinocandins for Injection Sales by Region
6.1.1 APAC Echinocandins for Injection Sales by Region (2021-2026)
6.1.2 APAC Echinocandins for Injection Revenue by Region (2021-2026)
6.2 APAC Echinocandins for Injection Sales by Type (2021-2026)
6.3 APAC Echinocandins for Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Echinocandins for Injection by Country
7.1.1 Europe Echinocandins for Injection Sales by Country (2021-2026)
7.1.2 Europe Echinocandins for Injection Revenue by Country (2021-2026)
7.2 Europe Echinocandins for Injection Sales by Type (2021-2026)
7.3 Europe Echinocandins for Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Echinocandins for Injection by Country
8.1.1 Middle East & Africa Echinocandins for Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Echinocandins for Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Echinocandins for Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Echinocandins for Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Echinocandins for Injection
10.3 Manufacturing Process Analysis of Echinocandins for Injection
10.4 Industry Chain Structure of Echinocandins for Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Echinocandins for Injection Distributors
11.3 Echinocandins for Injection Customer
12 WORLD FORECAST REVIEW FOR ECHINOCANDINS FOR INJECTION BY GEOGRAPHIC REGION
12.1 Global Echinocandins for Injection Market Size Forecast by Region
12.1.1 Global Echinocandins for Injection Forecast by Region (2027-2032)
12.1.2 Global Echinocandins for Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Echinocandins for Injection Forecast by Type (2027-2032)
12.7 Global Echinocandins for Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Echinocandins for Injection Product Portfolios and Specifications
13.1.3 Merck Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Astellas
13.2.1 Astellas Company Information
13.2.2 Astellas Echinocandins for Injection Product Portfolios and Specifications
13.2.3 Astellas Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Astellas Main Business Overview
13.2.5 Astellas Latest Developments
13.3 Endo International
13.3.1 Endo International Company Information
13.3.2 Endo International Echinocandins for Injection Product Portfolios and Specifications
13.3.3 Endo International Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Endo International Main Business Overview
13.3.5 Endo International Latest Developments
13.4 Xellia Pharmaceuticals
13.4.1 Xellia Pharmaceuticals Company Information
13.4.2 Xellia Pharmaceuticals Echinocandins for Injection Product Portfolios and Specifications
13.4.3 Xellia Pharmaceuticals Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Xellia Pharmaceuticals Main Business Overview
13.4.5 Xellia Pharmaceuticals Latest Developments
13.5 Teva
13.5.1 Teva Company Information
13.5.2 Teva Echinocandins for Injection Product Portfolios and Specifications
13.5.3 Teva Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Teva Main Business Overview
13.5.5 Teva Latest Developments
13.6 Hikma
13.6.1 Hikma Company Information
13.6.2 Hikma Echinocandins for Injection Product Portfolios and Specifications
13.6.3 Hikma Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hikma Main Business Overview
13.6.5 Hikma Latest Developments
13.7 Apotex
13.7.1 Apotex Company Information
13.7.2 Apotex Echinocandins for Injection Product Portfolios and Specifications
13.7.3 Apotex Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Apotex Main Business Overview
13.7.5 Apotex Latest Developments
13.8 Fresenius
13.8.1 Fresenius Company Information
13.8.2 Fresenius Echinocandins for Injection Product Portfolios and Specifications
13.8.3 Fresenius Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Fresenius Main Business Overview
13.8.5 Fresenius Latest Developments
13.9 Pfizer
13.9.1 Pfizer Company Information
13.9.2 Pfizer Echinocandins for Injection Product Portfolios and Specifications
13.9.3 Pfizer Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Pfizer Main Business Overview
13.9.5 Pfizer Latest Developments
13.10 CTTQ
13.10.1 CTTQ Company Information
13.10.2 CTTQ Echinocandins for Injection Product Portfolios and Specifications
13.10.3 CTTQ Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 CTTQ Main Business Overview
13.10.5 CTTQ Latest Developments
13.11 QILU Pharmaceutical
13.11.1 QILU Pharmaceutical Company Information
13.11.2 QILU Pharmaceutical Echinocandins for Injection Product Portfolios and Specifications
13.11.3 QILU Pharmaceutical Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 QILU Pharmaceutical Main Business Overview
13.11.5 QILU Pharmaceutical Latest Developments
13.12 BrightGene Bio-Medical Technology
13.12.1 BrightGene Bio-Medical Technology Company Information
13.12.2 BrightGene Bio-Medical Technology Echinocandins for Injection Product Portfolios and Specifications
13.12.3 BrightGene Bio-Medical Technology Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 BrightGene Bio-Medical Technology Main Business Overview
13.12.5 BrightGene Bio-Medical Technology Latest Developments
13.13 Hansoh Pharmaceutical
13.13.1 Hansoh Pharmaceutical Company Information
13.13.2 Hansoh Pharmaceutical Echinocandins for Injection Product Portfolios and Specifications
13.13.3 Hansoh Pharmaceutical Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Hansoh Pharmaceutical Main Business Overview
13.13.5 Hansoh Pharmaceutical Latest Developments
13.14 HISUN
13.14.1 HISUN Company Information
13.14.2 HISUN Echinocandins for Injection Product Portfolios and Specifications
13.14.3 HISUN Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 HISUN Main Business Overview
13.14.5 HISUN Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Echinocandins for Injection Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Echinocandins for Injection by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Echinocandins for Injection by Country/Region, 2021, 2025 & 2032
2.2 Echinocandins for Injection Segment by Type
2.2.1 Caspofungin
2.2.2 Micafungin
2.2.3 Anidulafungin
2.2.4 Echinocandins for Injection Sales by Type
2.2.4.1 Global Echinocandins for Injection Sales Market Share by Type (2021-2026)
2.2.4.2 Global Echinocandins for Injection Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Echinocandins for Injection Sale Price by Type (2021-2026)
2.3 Echinocandins for Injection Segment by Application
2.3.1 Hospital
2.3.2 Drugstore
2.3.3 Echinocandins for Injection Sales by Application
2.3.3.1 Global Echinocandins for Injection Sale Market Share by Application (2021-2026)
2.3.3.2 Global Echinocandins for Injection Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Echinocandins for Injection Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Echinocandins for Injection Breakdown Data by Company
3.1.1 Global Echinocandins for Injection Annual Sales by Company (2021-2026)
3.1.2 Global Echinocandins for Injection Sales Market Share by Company (2021-2026)
3.2 Global Echinocandins for Injection Annual Revenue by Company (2021-2026)
3.2.1 Global Echinocandins for Injection Revenue by Company (2021-2026)
3.2.2 Global Echinocandins for Injection Revenue Market Share by Company (2021-2026)
3.3 Global Echinocandins for Injection Sale Price by Company
3.4 Key Manufacturers Echinocandins for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Echinocandins for Injection Product Location Distribution
3.4.2 Players Echinocandins for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ECHINOCANDINS FOR INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Echinocandins for Injection Market Size by Geographic Region (2021-2026)
4.1.1 Global Echinocandins for Injection Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Echinocandins for Injection Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Echinocandins for Injection Market Size by Country/Region (2021-2026)
4.2.1 Global Echinocandins for Injection Annual Sales by Country/Region (2021-2026)
4.2.2 Global Echinocandins for Injection Annual Revenue by Country/Region (2021-2026)
4.3 Americas Echinocandins for Injection Sales Growth
4.4 APAC Echinocandins for Injection Sales Growth
4.5 Europe Echinocandins for Injection Sales Growth
4.6 Middle East & Africa Echinocandins for Injection Sales Growth
5 AMERICAS
5.1 Americas Echinocandins for Injection Sales by Country
5.1.1 Americas Echinocandins for Injection Sales by Country (2021-2026)
5.1.2 Americas Echinocandins for Injection Revenue by Country (2021-2026)
5.2 Americas Echinocandins for Injection Sales by Type (2021-2026)
5.3 Americas Echinocandins for Injection Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Echinocandins for Injection Sales by Region
6.1.1 APAC Echinocandins for Injection Sales by Region (2021-2026)
6.1.2 APAC Echinocandins for Injection Revenue by Region (2021-2026)
6.2 APAC Echinocandins for Injection Sales by Type (2021-2026)
6.3 APAC Echinocandins for Injection Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Echinocandins for Injection by Country
7.1.1 Europe Echinocandins for Injection Sales by Country (2021-2026)
7.1.2 Europe Echinocandins for Injection Revenue by Country (2021-2026)
7.2 Europe Echinocandins for Injection Sales by Type (2021-2026)
7.3 Europe Echinocandins for Injection Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Echinocandins for Injection by Country
8.1.1 Middle East & Africa Echinocandins for Injection Sales by Country (2021-2026)
8.1.2 Middle East & Africa Echinocandins for Injection Revenue by Country (2021-2026)
8.2 Middle East & Africa Echinocandins for Injection Sales by Type (2021-2026)
8.3 Middle East & Africa Echinocandins for Injection Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Echinocandins for Injection
10.3 Manufacturing Process Analysis of Echinocandins for Injection
10.4 Industry Chain Structure of Echinocandins for Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Echinocandins for Injection Distributors
11.3 Echinocandins for Injection Customer
12 WORLD FORECAST REVIEW FOR ECHINOCANDINS FOR INJECTION BY GEOGRAPHIC REGION
12.1 Global Echinocandins for Injection Market Size Forecast by Region
12.1.1 Global Echinocandins for Injection Forecast by Region (2027-2032)
12.1.2 Global Echinocandins for Injection Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Echinocandins for Injection Forecast by Type (2027-2032)
12.7 Global Echinocandins for Injection Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Echinocandins for Injection Product Portfolios and Specifications
13.1.3 Merck Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Astellas
13.2.1 Astellas Company Information
13.2.2 Astellas Echinocandins for Injection Product Portfolios and Specifications
13.2.3 Astellas Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Astellas Main Business Overview
13.2.5 Astellas Latest Developments
13.3 Endo International
13.3.1 Endo International Company Information
13.3.2 Endo International Echinocandins for Injection Product Portfolios and Specifications
13.3.3 Endo International Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Endo International Main Business Overview
13.3.5 Endo International Latest Developments
13.4 Xellia Pharmaceuticals
13.4.1 Xellia Pharmaceuticals Company Information
13.4.2 Xellia Pharmaceuticals Echinocandins for Injection Product Portfolios and Specifications
13.4.3 Xellia Pharmaceuticals Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Xellia Pharmaceuticals Main Business Overview
13.4.5 Xellia Pharmaceuticals Latest Developments
13.5 Teva
13.5.1 Teva Company Information
13.5.2 Teva Echinocandins for Injection Product Portfolios and Specifications
13.5.3 Teva Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Teva Main Business Overview
13.5.5 Teva Latest Developments
13.6 Hikma
13.6.1 Hikma Company Information
13.6.2 Hikma Echinocandins for Injection Product Portfolios and Specifications
13.6.3 Hikma Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hikma Main Business Overview
13.6.5 Hikma Latest Developments
13.7 Apotex
13.7.1 Apotex Company Information
13.7.2 Apotex Echinocandins for Injection Product Portfolios and Specifications
13.7.3 Apotex Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Apotex Main Business Overview
13.7.5 Apotex Latest Developments
13.8 Fresenius
13.8.1 Fresenius Company Information
13.8.2 Fresenius Echinocandins for Injection Product Portfolios and Specifications
13.8.3 Fresenius Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Fresenius Main Business Overview
13.8.5 Fresenius Latest Developments
13.9 Pfizer
13.9.1 Pfizer Company Information
13.9.2 Pfizer Echinocandins for Injection Product Portfolios and Specifications
13.9.3 Pfizer Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Pfizer Main Business Overview
13.9.5 Pfizer Latest Developments
13.10 CTTQ
13.10.1 CTTQ Company Information
13.10.2 CTTQ Echinocandins for Injection Product Portfolios and Specifications
13.10.3 CTTQ Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 CTTQ Main Business Overview
13.10.5 CTTQ Latest Developments
13.11 QILU Pharmaceutical
13.11.1 QILU Pharmaceutical Company Information
13.11.2 QILU Pharmaceutical Echinocandins for Injection Product Portfolios and Specifications
13.11.3 QILU Pharmaceutical Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 QILU Pharmaceutical Main Business Overview
13.11.5 QILU Pharmaceutical Latest Developments
13.12 BrightGene Bio-Medical Technology
13.12.1 BrightGene Bio-Medical Technology Company Information
13.12.2 BrightGene Bio-Medical Technology Echinocandins for Injection Product Portfolios and Specifications
13.12.3 BrightGene Bio-Medical Technology Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 BrightGene Bio-Medical Technology Main Business Overview
13.12.5 BrightGene Bio-Medical Technology Latest Developments
13.13 Hansoh Pharmaceutical
13.13.1 Hansoh Pharmaceutical Company Information
13.13.2 Hansoh Pharmaceutical Echinocandins for Injection Product Portfolios and Specifications
13.13.3 Hansoh Pharmaceutical Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Hansoh Pharmaceutical Main Business Overview
13.13.5 Hansoh Pharmaceutical Latest Developments
13.14 HISUN
13.14.1 HISUN Company Information
13.14.2 HISUN Echinocandins for Injection Product Portfolios and Specifications
13.14.3 HISUN Echinocandins for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 HISUN Main Business Overview
13.14.5 HISUN Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Echinocandins for Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Echinocandins for Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Caspofungin
Table 4. Major Players of Micafungin
Table 5. Major Players of Anidulafungin
Table 6. Global Echinocandins for Injection Sales by Type (2021-2026) & (K Units)
Table 7. Global Echinocandins for Injection Sales Market Share by Type (2021-2026)
Table 8. Global Echinocandins for Injection Revenue by Type (2021-2026) & ($ million)
Table 9. Global Echinocandins for Injection Revenue Market Share by Type (2021-2026)
Table 10. Global Echinocandins for Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Echinocandins for Injection Sale by Application (2021-2026) & (K Units)
Table 12. Global Echinocandins for Injection Sale Market Share by Application (2021-2026)
Table 13. Global Echinocandins for Injection Revenue by Application (2021-2026) & ($ million)
Table 14. Global Echinocandins for Injection Revenue Market Share by Application (2021-2026)
Table 15. Global Echinocandins for Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Echinocandins for Injection Sales by Company (2021-2026) & (K Units)
Table 17. Global Echinocandins for Injection Sales Market Share by Company (2021-2026)
Table 18. Global Echinocandins for Injection Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Echinocandins for Injection Revenue Market Share by Company (2021-2026)
Table 20. Global Echinocandins for Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Echinocandins for Injection Producing Area Distribution and Sales Area
Table 22. Players Echinocandins for Injection Products Offered
Table 23. Echinocandins for Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Echinocandins for Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Echinocandins for Injection Sales Market Share Geographic Region (2021-2026)
Table 28. Global Echinocandins for Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Echinocandins for Injection Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Echinocandins for Injection Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Echinocandins for Injection Sales Market Share by Country/Region (2021-2026)
Table 32. Global Echinocandins for Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Echinocandins for Injection Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Echinocandins for Injection Sales by Country (2021-2026) & (K Units)
Table 35. Americas Echinocandins for Injection Sales Market Share by Country (2021-2026)
Table 36. Americas Echinocandins for Injection Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Echinocandins for Injection Sales by Type (2021-2026) & (K Units)
Table 38. Americas Echinocandins for Injection Sales by Application (2021-2026) & (K Units)
Table 39. APAC Echinocandins for Injection Sales by Region (2021-2026) & (K Units)
Table 40. APAC Echinocandins for Injection Sales Market Share by Region (2021-2026)
Table 41. APAC Echinocandins for Injection Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Echinocandins for Injection Sales by Type (2021-2026) & (K Units)
Table 43. APAC Echinocandins for Injection Sales by Application (2021-2026) & (K Units)
Table 44. Europe Echinocandins for Injection Sales by Country (2021-2026) & (K Units)
Table 45. Europe Echinocandins for Injection Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Echinocandins for Injection Sales by Type (2021-2026) & (K Units)
Table 47. Europe Echinocandins for Injection Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Echinocandins for Injection Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Echinocandins for Injection Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Echinocandins for Injection Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Echinocandins for Injection Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Echinocandins for Injection
Table 53. Key Market Challenges & Risks of Echinocandins for Injection
Table 54. Key Industry Trends of Echinocandins for Injection
Table 55. Echinocandins for Injection Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Echinocandins for Injection Distributors List
Table 58. Echinocandins for Injection Customer List
Table 59. Global Echinocandins for Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Echinocandins for Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Echinocandins for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Echinocandins for Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Echinocandins for Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Echinocandins for Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Echinocandins for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Echinocandins for Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Echinocandins for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Echinocandins for Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Echinocandins for Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Echinocandins for Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Echinocandins for Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Echinocandins for Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Merck Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck Echinocandins for Injection Product Portfolios and Specifications
Table 75. Merck Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Merck Main Business
Table 77. Merck Latest Developments
Table 78. Astellas Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Astellas Echinocandins for Injection Product Portfolios and Specifications
Table 80. Astellas Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Astellas Main Business
Table 82. Astellas Latest Developments
Table 83. Endo International Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Endo International Echinocandins for Injection Product Portfolios and Specifications
Table 85. Endo International Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Endo International Main Business
Table 87. Endo International Latest Developments
Table 88. Xellia Pharmaceuticals Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. Xellia Pharmaceuticals Echinocandins for Injection Product Portfolios and Specifications
Table 90. Xellia Pharmaceuticals Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Xellia Pharmaceuticals Main Business
Table 92. Xellia Pharmaceuticals Latest Developments
Table 93. Teva Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Teva Echinocandins for Injection Product Portfolios and Specifications
Table 95. Teva Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Teva Main Business
Table 97. Teva Latest Developments
Table 98. Hikma Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Hikma Echinocandins for Injection Product Portfolios and Specifications
Table 100. Hikma Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Hikma Main Business
Table 102. Hikma Latest Developments
Table 103. Apotex Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Apotex Echinocandins for Injection Product Portfolios and Specifications
Table 105. Apotex Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Apotex Main Business
Table 107. Apotex Latest Developments
Table 108. Fresenius Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Fresenius Echinocandins for Injection Product Portfolios and Specifications
Table 110. Fresenius Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Fresenius Main Business
Table 112. Fresenius Latest Developments
Table 113. Pfizer Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Pfizer Echinocandins for Injection Product Portfolios and Specifications
Table 115. Pfizer Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Pfizer Main Business
Table 117. Pfizer Latest Developments
Table 118. CTTQ Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. CTTQ Echinocandins for Injection Product Portfolios and Specifications
Table 120. CTTQ Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. CTTQ Main Business
Table 122. CTTQ Latest Developments
Table 123. QILU Pharmaceutical Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. QILU Pharmaceutical Echinocandins for Injection Product Portfolios and Specifications
Table 125. QILU Pharmaceutical Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. QILU Pharmaceutical Main Business
Table 127. QILU Pharmaceutical Latest Developments
Table 128. BrightGene Bio-Medical Technology Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. BrightGene Bio-Medical Technology Echinocandins for Injection Product Portfolios and Specifications
Table 130. BrightGene Bio-Medical Technology Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. BrightGene Bio-Medical Technology Main Business
Table 132. BrightGene Bio-Medical Technology Latest Developments
Table 133. Hansoh Pharmaceutical Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. Hansoh Pharmaceutical Echinocandins for Injection Product Portfolios and Specifications
Table 135. Hansoh Pharmaceutical Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Hansoh Pharmaceutical Main Business
Table 137. Hansoh Pharmaceutical Latest Developments
Table 138. HISUN Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. HISUN Echinocandins for Injection Product Portfolios and Specifications
Table 140. HISUN Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. HISUN Main Business
Table 142. HISUN Latest Developments
Table 1. Echinocandins for Injection Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Echinocandins for Injection Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Caspofungin
Table 4. Major Players of Micafungin
Table 5. Major Players of Anidulafungin
Table 6. Global Echinocandins for Injection Sales by Type (2021-2026) & (K Units)
Table 7. Global Echinocandins for Injection Sales Market Share by Type (2021-2026)
Table 8. Global Echinocandins for Injection Revenue by Type (2021-2026) & ($ million)
Table 9. Global Echinocandins for Injection Revenue Market Share by Type (2021-2026)
Table 10. Global Echinocandins for Injection Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Echinocandins for Injection Sale by Application (2021-2026) & (K Units)
Table 12. Global Echinocandins for Injection Sale Market Share by Application (2021-2026)
Table 13. Global Echinocandins for Injection Revenue by Application (2021-2026) & ($ million)
Table 14. Global Echinocandins for Injection Revenue Market Share by Application (2021-2026)
Table 15. Global Echinocandins for Injection Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Echinocandins for Injection Sales by Company (2021-2026) & (K Units)
Table 17. Global Echinocandins for Injection Sales Market Share by Company (2021-2026)
Table 18. Global Echinocandins for Injection Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Echinocandins for Injection Revenue Market Share by Company (2021-2026)
Table 20. Global Echinocandins for Injection Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Echinocandins for Injection Producing Area Distribution and Sales Area
Table 22. Players Echinocandins for Injection Products Offered
Table 23. Echinocandins for Injection Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Echinocandins for Injection Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Echinocandins for Injection Sales Market Share Geographic Region (2021-2026)
Table 28. Global Echinocandins for Injection Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Echinocandins for Injection Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Echinocandins for Injection Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Echinocandins for Injection Sales Market Share by Country/Region (2021-2026)
Table 32. Global Echinocandins for Injection Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Echinocandins for Injection Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Echinocandins for Injection Sales by Country (2021-2026) & (K Units)
Table 35. Americas Echinocandins for Injection Sales Market Share by Country (2021-2026)
Table 36. Americas Echinocandins for Injection Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Echinocandins for Injection Sales by Type (2021-2026) & (K Units)
Table 38. Americas Echinocandins for Injection Sales by Application (2021-2026) & (K Units)
Table 39. APAC Echinocandins for Injection Sales by Region (2021-2026) & (K Units)
Table 40. APAC Echinocandins for Injection Sales Market Share by Region (2021-2026)
Table 41. APAC Echinocandins for Injection Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Echinocandins for Injection Sales by Type (2021-2026) & (K Units)
Table 43. APAC Echinocandins for Injection Sales by Application (2021-2026) & (K Units)
Table 44. Europe Echinocandins for Injection Sales by Country (2021-2026) & (K Units)
Table 45. Europe Echinocandins for Injection Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Echinocandins for Injection Sales by Type (2021-2026) & (K Units)
Table 47. Europe Echinocandins for Injection Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Echinocandins for Injection Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Echinocandins for Injection Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Echinocandins for Injection Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Echinocandins for Injection Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Echinocandins for Injection
Table 53. Key Market Challenges & Risks of Echinocandins for Injection
Table 54. Key Industry Trends of Echinocandins for Injection
Table 55. Echinocandins for Injection Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Echinocandins for Injection Distributors List
Table 58. Echinocandins for Injection Customer List
Table 59. Global Echinocandins for Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Echinocandins for Injection Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Echinocandins for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Echinocandins for Injection Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Echinocandins for Injection Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Echinocandins for Injection Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Echinocandins for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Echinocandins for Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Echinocandins for Injection Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Echinocandins for Injection Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Echinocandins for Injection Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Echinocandins for Injection Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Echinocandins for Injection Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Echinocandins for Injection Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Merck Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 74. Merck Echinocandins for Injection Product Portfolios and Specifications
Table 75. Merck Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Merck Main Business
Table 77. Merck Latest Developments
Table 78. Astellas Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Astellas Echinocandins for Injection Product Portfolios and Specifications
Table 80. Astellas Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Astellas Main Business
Table 82. Astellas Latest Developments
Table 83. Endo International Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Endo International Echinocandins for Injection Product Portfolios and Specifications
Table 85. Endo International Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Endo International Main Business
Table 87. Endo International Latest Developments
Table 88. Xellia Pharmaceuticals Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. Xellia Pharmaceuticals Echinocandins for Injection Product Portfolios and Specifications
Table 90. Xellia Pharmaceuticals Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Xellia Pharmaceuticals Main Business
Table 92. Xellia Pharmaceuticals Latest Developments
Table 93. Teva Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Teva Echinocandins for Injection Product Portfolios and Specifications
Table 95. Teva Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Teva Main Business
Table 97. Teva Latest Developments
Table 98. Hikma Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Hikma Echinocandins for Injection Product Portfolios and Specifications
Table 100. Hikma Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Hikma Main Business
Table 102. Hikma Latest Developments
Table 103. Apotex Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Apotex Echinocandins for Injection Product Portfolios and Specifications
Table 105. Apotex Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Apotex Main Business
Table 107. Apotex Latest Developments
Table 108. Fresenius Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Fresenius Echinocandins for Injection Product Portfolios and Specifications
Table 110. Fresenius Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Fresenius Main Business
Table 112. Fresenius Latest Developments
Table 113. Pfizer Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Pfizer Echinocandins for Injection Product Portfolios and Specifications
Table 115. Pfizer Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Pfizer Main Business
Table 117. Pfizer Latest Developments
Table 118. CTTQ Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. CTTQ Echinocandins for Injection Product Portfolios and Specifications
Table 120. CTTQ Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. CTTQ Main Business
Table 122. CTTQ Latest Developments
Table 123. QILU Pharmaceutical Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. QILU Pharmaceutical Echinocandins for Injection Product Portfolios and Specifications
Table 125. QILU Pharmaceutical Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. QILU Pharmaceutical Main Business
Table 127. QILU Pharmaceutical Latest Developments
Table 128. BrightGene Bio-Medical Technology Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. BrightGene Bio-Medical Technology Echinocandins for Injection Product Portfolios and Specifications
Table 130. BrightGene Bio-Medical Technology Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. BrightGene Bio-Medical Technology Main Business
Table 132. BrightGene Bio-Medical Technology Latest Developments
Table 133. Hansoh Pharmaceutical Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. Hansoh Pharmaceutical Echinocandins for Injection Product Portfolios and Specifications
Table 135. Hansoh Pharmaceutical Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Hansoh Pharmaceutical Main Business
Table 137. Hansoh Pharmaceutical Latest Developments
Table 138. HISUN Basic Information, Echinocandins for Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. HISUN Echinocandins for Injection Product Portfolios and Specifications
Table 140. HISUN Echinocandins for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. HISUN Main Business
Table 142. HISUN Latest Developments
LIST OF FIGURES
Figure 1. Picture of Echinocandins for Injection
Figure 2. Echinocandins for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Echinocandins for Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Echinocandins for Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Echinocandins for Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Echinocandins for Injection Sales Market Share by Country/Region (2025)
Figure 10. Echinocandins for Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Caspofungin
Figure 12. Product Picture of Micafungin
Figure 13. Product Picture of Anidulafungin
Figure 14. Global Echinocandins for Injection Sales Market Share by Type in 2026
Figure 15. Global Echinocandins for Injection Revenue Market Share by Type (2021-2026)
Figure 16. Echinocandins for Injection Consumed in Hospital
Figure 17. Global Echinocandins for Injection Market: Hospital (2021-2026) & (K Units)
Figure 18. Echinocandins for Injection Consumed in Drugstore
Figure 19. Global Echinocandins for Injection Market: Drugstore (2021-2026) & (K Units)
Figure 20. Global Echinocandins for Injection Sale Market Share by Application (2025)
Figure 21. Global Echinocandins for Injection Revenue Market Share by Application in 2026
Figure 22. Echinocandins for Injection Sales by Company in 2026 (K Units)
Figure 23. Global Echinocandins for Injection Sales Market Share by Company in 2026
Figure 24. Echinocandins for Injection Revenue by Company in 2026 ($ millions)
Figure 25. Global Echinocandins for Injection Revenue Market Share by Company in 2026
Figure 26. Global Echinocandins for Injection Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Echinocandins for Injection Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Echinocandins for Injection Sales 2021-2026 (K Units)
Figure 29. Americas Echinocandins for Injection Revenue 2021-2026 ($ millions)
Figure 30. APAC Echinocandins for Injection Sales 2021-2026 (K Units)
Figure 31. APAC Echinocandins for Injection Revenue 2021-2026 ($ millions)
Figure 32. Europe Echinocandins for Injection Sales 2021-2026 (K Units)
Figure 33. Europe Echinocandins for Injection Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Echinocandins for Injection Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa Echinocandins for Injection Revenue 2021-2026 ($ millions)
Figure 36. Americas Echinocandins for Injection Sales Market Share by Country in 2026
Figure 37. Americas Echinocandins for Injection Revenue Market Share by Country (2021-2026)
Figure 38. Americas Echinocandins for Injection Sales Market Share by Type (2021-2026)
Figure 39. Americas Echinocandins for Injection Sales Market Share by Application (2021-2026)
Figure 40. United States Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Echinocandins for Injection Sales Market Share by Region in 2026
Figure 45. APAC Echinocandins for Injection Revenue Market Share by Region (2021-2026)
Figure 46. APAC Echinocandins for Injection Sales Market Share by Type (2021-2026)
Figure 47. APAC Echinocandins for Injection Sales Market Share by Application (2021-2026)
Figure 48. China Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. India Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Echinocandins for Injection Sales Market Share by Country in 2026
Figure 56. Europe Echinocandins for Injection Revenue Market Share by Country (2021-2026)
Figure 57. Europe Echinocandins for Injection Sales Market Share by Type (2021-2026)
Figure 58. Europe Echinocandins for Injection Sales Market Share by Application (2021-2026)
Figure 59. Germany Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 60. France Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Echinocandins for Injection Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Echinocandins for Injection Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Echinocandins for Injection Sales Market Share by Application (2021-2026)
Figure 67. Egypt Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Echinocandins for Injection in 2026
Figure 73. Manufacturing Process Analysis of Echinocandins for Injection
Figure 74. Industry Chain Structure of Echinocandins for Injection
Figure 75. Channels of Distribution
Figure 76. Global Echinocandins for Injection Sales Market Forecast by Region (2027-2032)
Figure 77. Global Echinocandins for Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Echinocandins for Injection Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Echinocandins for Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Echinocandins for Injection Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Echinocandins for Injection Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Echinocandins for Injection
Figure 2. Echinocandins for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Echinocandins for Injection Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Echinocandins for Injection Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Echinocandins for Injection Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Echinocandins for Injection Sales Market Share by Country/Region (2025)
Figure 10. Echinocandins for Injection Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Caspofungin
Figure 12. Product Picture of Micafungin
Figure 13. Product Picture of Anidulafungin
Figure 14. Global Echinocandins for Injection Sales Market Share by Type in 2026
Figure 15. Global Echinocandins for Injection Revenue Market Share by Type (2021-2026)
Figure 16. Echinocandins for Injection Consumed in Hospital
Figure 17. Global Echinocandins for Injection Market: Hospital (2021-2026) & (K Units)
Figure 18. Echinocandins for Injection Consumed in Drugstore
Figure 19. Global Echinocandins for Injection Market: Drugstore (2021-2026) & (K Units)
Figure 20. Global Echinocandins for Injection Sale Market Share by Application (2025)
Figure 21. Global Echinocandins for Injection Revenue Market Share by Application in 2026
Figure 22. Echinocandins for Injection Sales by Company in 2026 (K Units)
Figure 23. Global Echinocandins for Injection Sales Market Share by Company in 2026
Figure 24. Echinocandins for Injection Revenue by Company in 2026 ($ millions)
Figure 25. Global Echinocandins for Injection Revenue Market Share by Company in 2026
Figure 26. Global Echinocandins for Injection Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Echinocandins for Injection Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Echinocandins for Injection Sales 2021-2026 (K Units)
Figure 29. Americas Echinocandins for Injection Revenue 2021-2026 ($ millions)
Figure 30. APAC Echinocandins for Injection Sales 2021-2026 (K Units)
Figure 31. APAC Echinocandins for Injection Revenue 2021-2026 ($ millions)
Figure 32. Europe Echinocandins for Injection Sales 2021-2026 (K Units)
Figure 33. Europe Echinocandins for Injection Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Echinocandins for Injection Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa Echinocandins for Injection Revenue 2021-2026 ($ millions)
Figure 36. Americas Echinocandins for Injection Sales Market Share by Country in 2026
Figure 37. Americas Echinocandins for Injection Revenue Market Share by Country (2021-2026)
Figure 38. Americas Echinocandins for Injection Sales Market Share by Type (2021-2026)
Figure 39. Americas Echinocandins for Injection Sales Market Share by Application (2021-2026)
Figure 40. United States Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Echinocandins for Injection Sales Market Share by Region in 2026
Figure 45. APAC Echinocandins for Injection Revenue Market Share by Region (2021-2026)
Figure 46. APAC Echinocandins for Injection Sales Market Share by Type (2021-2026)
Figure 47. APAC Echinocandins for Injection Sales Market Share by Application (2021-2026)
Figure 48. China Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 52. India Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Echinocandins for Injection Sales Market Share by Country in 2026
Figure 56. Europe Echinocandins for Injection Revenue Market Share by Country (2021-2026)
Figure 57. Europe Echinocandins for Injection Sales Market Share by Type (2021-2026)
Figure 58. Europe Echinocandins for Injection Sales Market Share by Application (2021-2026)
Figure 59. Germany Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 60. France Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Echinocandins for Injection Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Echinocandins for Injection Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Echinocandins for Injection Sales Market Share by Application (2021-2026)
Figure 67. Egypt Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Echinocandins for Injection Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Echinocandins for Injection in 2026
Figure 73. Manufacturing Process Analysis of Echinocandins for Injection
Figure 74. Industry Chain Structure of Echinocandins for Injection
Figure 75. Channels of Distribution
Figure 76. Global Echinocandins for Injection Sales Market Forecast by Region (2027-2032)
Figure 77. Global Echinocandins for Injection Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Echinocandins for Injection Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Echinocandins for Injection Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Echinocandins for Injection Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Echinocandins for Injection Revenue Market Share Forecast by Application (2027-2032)
